|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clopidol |
CAS 2971-90-6 | ||
C7H7Cl2NO |
RTECS UU7711500 | ||
|
Synonyms & Trade Names Coyden®; 3,5-Dichloro-2,6-dimethyl-4-pyridinol |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: TWA 10 mg/m3 (total) ST 20 mg/m3 (total) TWA 5 mg/m3 (resp) | ||
| OSHA PEL: TWA 15 mg/m3 (total) TWA 5 mg/m3 (resp) | |||
| IDLH N.D. See: IDLH INDEX | Conversion | ||
|
Physical Description White to light-brown, crystalline solid. |
|||
|
MW: 192.1 |
BP: ? |
MLT: >608°F |
Sol: Insoluble |
|
VP: ? |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid, but dust may explode in cloud form. | |||
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods NIOSH 0500, 0600 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: No recommendation Eyes: No recommendation Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Fresh air |
|
Important additional information about respirator selection Respirator Recommendations Not available. |
|
| Exposure Routes inhalation, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, nose, throat; cough | |
|
Target Organs
Eyes, skin, respiratory system |
|
| See also: INTRODUCTION |